Loading…

Phage Therapy as a Focused Management Strategy in Aquaculture

Therapeutic bacteriophages, commonly called as phages, are a promising potential alternative to antibiotics in the management of bacterial infections of a wide range of organisms including cultured fish. Their natural immunogenicity often induces the modulation of a variated collection of immune res...

Full description

Saved in:
Bibliographic Details
Published in:International journal of molecular sciences 2021-09, Vol.22 (19), p.10436
Main Authors: Ramos-Vivas, José, Superio, Joshua, Galindo-Villegas, Jorge, Acosta, Félix
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c415t-67dbd09f3dea924bf19e61c1eadc64e45b0c553cd43aead88f945761118a59bf3
cites cdi_FETCH-LOGICAL-c415t-67dbd09f3dea924bf19e61c1eadc64e45b0c553cd43aead88f945761118a59bf3
container_end_page
container_issue 19
container_start_page 10436
container_title International journal of molecular sciences
container_volume 22
creator Ramos-Vivas, José
Superio, Joshua
Galindo-Villegas, Jorge
Acosta, Félix
description Therapeutic bacteriophages, commonly called as phages, are a promising potential alternative to antibiotics in the management of bacterial infections of a wide range of organisms including cultured fish. Their natural immunogenicity often induces the modulation of a variated collection of immune responses within several types of immunocytes while promoting specific mechanisms of bacterial clearance. However, to achieve standardized treatments at the practical level and avoid possible side effects in cultivated fish, several improvements in the understanding of their biology and the associated genomes are required. Interestingly, a particular feature with therapeutic potential among all phages is the production of lytic enzymes. The use of such enzymes against human and livestock pathogens has already provided in vitro and in vivo promissory results. So far, the best-understood phages utilized to fight against either Gram-negative or Gram-positive bacterial species in fish culture are mainly restricted to the and , and the , respectively. However, the current functional use of phages against bacterial pathogens of cultured fish is still in its infancy. Based on the available data, in this review, we summarize the current knowledge about phage, identify gaps, and provide insights into the possible bacterial control strategies they might represent for managing aquaculture-related bacterial diseases.
doi_str_mv 10.3390/ijms221910436
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8508683</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2581021043</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-67dbd09f3dea924bf19e61c1eadc64e45b0c553cd43aead88f945761118a59bf3</originalsourceid><addsrcrecordid>eNpdkc1LAzEQxYMotlaPXmXBi5fVfG_2oFCKVaGiYD2HbDbbbtmPNtkI_e9NbS3W0wwzPx7z5gFwieAtISm8Kxe1wxilCFLCj0AfUYxjCHly_KfvgTPnFhBigll6CnqEciKShPfB_ftczUw0nRurlutIuUhF41Z7Z_LoVTVhV5umiz46qzozW0dlEw1XXmlfdd6ac3BSqMqZi10dgM_x43T0HE_enl5Gw0msKWJdzJM8y2FakNyoFNOsQKnhSCOjcs2poSyDmjGic0pUmAlRpJQlHCEkFEuzggzAw1Z36bPa5DqcZFUll7aslV3LVpXycNOUczlrv6RgUHBBgsDNTsC2K29cJ-vSaVNVqjGtdxIzgQQWCIqAXv9DF623TbD3Q0G8-XSg4i2lbeucNcX-GATlJhh5EEzgr_462NO_SZBvUOeJmg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2581021043</pqid></control><display><type>article</type><title>Phage Therapy as a Focused Management Strategy in Aquaculture</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Ramos-Vivas, José ; Superio, Joshua ; Galindo-Villegas, Jorge ; Acosta, Félix</creator><creatorcontrib>Ramos-Vivas, José ; Superio, Joshua ; Galindo-Villegas, Jorge ; Acosta, Félix</creatorcontrib><description>Therapeutic bacteriophages, commonly called as phages, are a promising potential alternative to antibiotics in the management of bacterial infections of a wide range of organisms including cultured fish. Their natural immunogenicity often induces the modulation of a variated collection of immune responses within several types of immunocytes while promoting specific mechanisms of bacterial clearance. However, to achieve standardized treatments at the practical level and avoid possible side effects in cultivated fish, several improvements in the understanding of their biology and the associated genomes are required. Interestingly, a particular feature with therapeutic potential among all phages is the production of lytic enzymes. The use of such enzymes against human and livestock pathogens has already provided in vitro and in vivo promissory results. So far, the best-understood phages utilized to fight against either Gram-negative or Gram-positive bacterial species in fish culture are mainly restricted to the and , and the , respectively. However, the current functional use of phages against bacterial pathogens of cultured fish is still in its infancy. Based on the available data, in this review, we summarize the current knowledge about phage, identify gaps, and provide insights into the possible bacterial control strategies they might represent for managing aquaculture-related bacterial diseases.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms221910436</identifier><identifier>PMID: 34638776</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Animals ; Antibiotics ; Aquaculture ; Bacteria ; Bacterial infections ; Bacterial Infections - therapy ; Bacterial Infections - virology ; Biofilms ; Cell division ; Enzymes ; Fish culture ; Genes ; Genomes ; Gram-negative bacteria ; Gram-positive bacteria ; Humans ; Immune clearance ; Immune response ; Immune system ; Immunogenicity ; Immunomodulation ; Livestock ; Lytic enzymes ; Medical research ; Myoviridae ; Pathogens ; Phage Therapy ; Phages ; Podoviridae ; Proteins ; Review ; Siphoviridae ; Viruses</subject><ispartof>International journal of molecular sciences, 2021-09, Vol.22 (19), p.10436</ispartof><rights>2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 by the authors. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-67dbd09f3dea924bf19e61c1eadc64e45b0c553cd43aead88f945761118a59bf3</citedby><cites>FETCH-LOGICAL-c415t-67dbd09f3dea924bf19e61c1eadc64e45b0c553cd43aead88f945761118a59bf3</cites><orcidid>0000-0002-4250-2477 ; 0000-0002-1098-7529 ; 0000-0002-8509-2463</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2581021043/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2581021043?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34638776$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ramos-Vivas, José</creatorcontrib><creatorcontrib>Superio, Joshua</creatorcontrib><creatorcontrib>Galindo-Villegas, Jorge</creatorcontrib><creatorcontrib>Acosta, Félix</creatorcontrib><title>Phage Therapy as a Focused Management Strategy in Aquaculture</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>Therapeutic bacteriophages, commonly called as phages, are a promising potential alternative to antibiotics in the management of bacterial infections of a wide range of organisms including cultured fish. Their natural immunogenicity often induces the modulation of a variated collection of immune responses within several types of immunocytes while promoting specific mechanisms of bacterial clearance. However, to achieve standardized treatments at the practical level and avoid possible side effects in cultivated fish, several improvements in the understanding of their biology and the associated genomes are required. Interestingly, a particular feature with therapeutic potential among all phages is the production of lytic enzymes. The use of such enzymes against human and livestock pathogens has already provided in vitro and in vivo promissory results. So far, the best-understood phages utilized to fight against either Gram-negative or Gram-positive bacterial species in fish culture are mainly restricted to the and , and the , respectively. However, the current functional use of phages against bacterial pathogens of cultured fish is still in its infancy. Based on the available data, in this review, we summarize the current knowledge about phage, identify gaps, and provide insights into the possible bacterial control strategies they might represent for managing aquaculture-related bacterial diseases.</description><subject>Animals</subject><subject>Antibiotics</subject><subject>Aquaculture</subject><subject>Bacteria</subject><subject>Bacterial infections</subject><subject>Bacterial Infections - therapy</subject><subject>Bacterial Infections - virology</subject><subject>Biofilms</subject><subject>Cell division</subject><subject>Enzymes</subject><subject>Fish culture</subject><subject>Genes</subject><subject>Genomes</subject><subject>Gram-negative bacteria</subject><subject>Gram-positive bacteria</subject><subject>Humans</subject><subject>Immune clearance</subject><subject>Immune response</subject><subject>Immune system</subject><subject>Immunogenicity</subject><subject>Immunomodulation</subject><subject>Livestock</subject><subject>Lytic enzymes</subject><subject>Medical research</subject><subject>Myoviridae</subject><subject>Pathogens</subject><subject>Phage Therapy</subject><subject>Phages</subject><subject>Podoviridae</subject><subject>Proteins</subject><subject>Review</subject><subject>Siphoviridae</subject><subject>Viruses</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdkc1LAzEQxYMotlaPXmXBi5fVfG_2oFCKVaGiYD2HbDbbbtmPNtkI_e9NbS3W0wwzPx7z5gFwieAtISm8Kxe1wxilCFLCj0AfUYxjCHly_KfvgTPnFhBigll6CnqEciKShPfB_ftczUw0nRurlutIuUhF41Z7Z_LoVTVhV5umiz46qzozW0dlEw1XXmlfdd6ac3BSqMqZi10dgM_x43T0HE_enl5Gw0msKWJdzJM8y2FakNyoFNOsQKnhSCOjcs2poSyDmjGic0pUmAlRpJQlHCEkFEuzggzAw1Z36bPa5DqcZFUll7aslV3LVpXycNOUczlrv6RgUHBBgsDNTsC2K29cJ-vSaVNVqjGtdxIzgQQWCIqAXv9DF623TbD3Q0G8-XSg4i2lbeucNcX-GATlJhh5EEzgr_462NO_SZBvUOeJmg</recordid><startdate>20210928</startdate><enddate>20210928</enddate><creator>Ramos-Vivas, José</creator><creator>Superio, Joshua</creator><creator>Galindo-Villegas, Jorge</creator><creator>Acosta, Félix</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-4250-2477</orcidid><orcidid>https://orcid.org/0000-0002-1098-7529</orcidid><orcidid>https://orcid.org/0000-0002-8509-2463</orcidid></search><sort><creationdate>20210928</creationdate><title>Phage Therapy as a Focused Management Strategy in Aquaculture</title><author>Ramos-Vivas, José ; Superio, Joshua ; Galindo-Villegas, Jorge ; Acosta, Félix</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-67dbd09f3dea924bf19e61c1eadc64e45b0c553cd43aead88f945761118a59bf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Animals</topic><topic>Antibiotics</topic><topic>Aquaculture</topic><topic>Bacteria</topic><topic>Bacterial infections</topic><topic>Bacterial Infections - therapy</topic><topic>Bacterial Infections - virology</topic><topic>Biofilms</topic><topic>Cell division</topic><topic>Enzymes</topic><topic>Fish culture</topic><topic>Genes</topic><topic>Genomes</topic><topic>Gram-negative bacteria</topic><topic>Gram-positive bacteria</topic><topic>Humans</topic><topic>Immune clearance</topic><topic>Immune response</topic><topic>Immune system</topic><topic>Immunogenicity</topic><topic>Immunomodulation</topic><topic>Livestock</topic><topic>Lytic enzymes</topic><topic>Medical research</topic><topic>Myoviridae</topic><topic>Pathogens</topic><topic>Phage Therapy</topic><topic>Phages</topic><topic>Podoviridae</topic><topic>Proteins</topic><topic>Review</topic><topic>Siphoviridae</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ramos-Vivas, José</creatorcontrib><creatorcontrib>Superio, Joshua</creatorcontrib><creatorcontrib>Galindo-Villegas, Jorge</creatorcontrib><creatorcontrib>Acosta, Félix</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Hospital Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Research Library</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>PML(ProQuest Medical Library)</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest Health &amp; Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health &amp; Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ramos-Vivas, José</au><au>Superio, Joshua</au><au>Galindo-Villegas, Jorge</au><au>Acosta, Félix</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phage Therapy as a Focused Management Strategy in Aquaculture</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2021-09-28</date><risdate>2021</risdate><volume>22</volume><issue>19</issue><spage>10436</spage><pages>10436-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Therapeutic bacteriophages, commonly called as phages, are a promising potential alternative to antibiotics in the management of bacterial infections of a wide range of organisms including cultured fish. Their natural immunogenicity often induces the modulation of a variated collection of immune responses within several types of immunocytes while promoting specific mechanisms of bacterial clearance. However, to achieve standardized treatments at the practical level and avoid possible side effects in cultivated fish, several improvements in the understanding of their biology and the associated genomes are required. Interestingly, a particular feature with therapeutic potential among all phages is the production of lytic enzymes. The use of such enzymes against human and livestock pathogens has already provided in vitro and in vivo promissory results. So far, the best-understood phages utilized to fight against either Gram-negative or Gram-positive bacterial species in fish culture are mainly restricted to the and , and the , respectively. However, the current functional use of phages against bacterial pathogens of cultured fish is still in its infancy. Based on the available data, in this review, we summarize the current knowledge about phage, identify gaps, and provide insights into the possible bacterial control strategies they might represent for managing aquaculture-related bacterial diseases.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>34638776</pmid><doi>10.3390/ijms221910436</doi><orcidid>https://orcid.org/0000-0002-4250-2477</orcidid><orcidid>https://orcid.org/0000-0002-1098-7529</orcidid><orcidid>https://orcid.org/0000-0002-8509-2463</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1422-0067
ispartof International journal of molecular sciences, 2021-09, Vol.22 (19), p.10436
issn 1422-0067
1661-6596
1422-0067
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8508683
source Publicly Available Content Database; PubMed Central
subjects Animals
Antibiotics
Aquaculture
Bacteria
Bacterial infections
Bacterial Infections - therapy
Bacterial Infections - virology
Biofilms
Cell division
Enzymes
Fish culture
Genes
Genomes
Gram-negative bacteria
Gram-positive bacteria
Humans
Immune clearance
Immune response
Immune system
Immunogenicity
Immunomodulation
Livestock
Lytic enzymes
Medical research
Myoviridae
Pathogens
Phage Therapy
Phages
Podoviridae
Proteins
Review
Siphoviridae
Viruses
title Phage Therapy as a Focused Management Strategy in Aquaculture
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-03-06T15%3A24%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phage%20Therapy%20as%20a%20Focused%20Management%20Strategy%20in%20Aquaculture&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Ramos-Vivas,%20Jos%C3%A9&rft.date=2021-09-28&rft.volume=22&rft.issue=19&rft.spage=10436&rft.pages=10436-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms221910436&rft_dat=%3Cproquest_pubme%3E2581021043%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c415t-67dbd09f3dea924bf19e61c1eadc64e45b0c553cd43aead88f945761118a59bf3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2581021043&rft_id=info:pmid/34638776&rfr_iscdi=true